{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(24)"],"submitter":["Salaffi F"],"pubmed_abstract":["The term \"axial spondyloarthritis\" (axSpA) refers to a group of chronic rheumatic diseases that predominantly involve the axial skeleton and consist of ankylosing spondylitis, reactive arthritis, arthritis/spondylitis associated with psoriasis (PsA) and arthritis/spondylitis associated with inflammatory bowel diseases (IBD). Moreover, pain is an important and common symptom of axSpA. It may progress to chronic pain, a more complicated bio-psychosocial phenomena, leading to a significant worsening of quality of life. The development of the axSpA inflammatory process is grounded in the complex interaction between genetic (such as HLA B27), epigenetic, and environmental factors associated with a dysregulated immune response. Considering the pivotal contribution of IL-23 and IL-17 in axSpA inf"],"journal":["Journal of clinical medicine"],"pagination":["7537"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9780899"],"repository":["biostudies-literature"],"pubmed_title":["Axial Spondyloarthritis: Reshape the Future-From the \"2022 GISEA International Symposium\"."],"pmcid":["PMC9780899"],"pubmed_authors":["Alciati A","Siragusano C","Guiducci S","Favalli EG","D'Angelo S","Caporali R","Atzeni F","Lapadula G","Conti F","Gremese E","Iannone F","Ferraccioli GF","Salaffi F","Cassone G","Sebastiani M"],"additional_accession":[]},"is_claimable":false,"name":"Axial Spondyloarthritis: Reshape the Future-From the \"2022 GISEA International Symposium\".","description":"The term \"axial spondyloarthritis\" (axSpA) refers to a group of chronic rheumatic diseases that predominantly involve the axial skeleton and consist of ankylosing spondylitis, reactive arthritis, arthritis/spondylitis associated with psoriasis (PsA) and arthritis/spondylitis associated with inflammatory bowel diseases (IBD). Moreover, pain is an important and common symptom of axSpA. It may progress to chronic pain, a more complicated bio-psychosocial phenomena, leading to a significant worsening of quality of life. The development of the axSpA inflammatory process is grounded in the complex interaction between genetic (such as HLA B27), epigenetic, and environmental factors associated with a dysregulated immune response. Considering the pivotal contribution of IL-23 and IL-17 in axSpA inf","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-21T14:15:22.153Z","creation":"2025-02-19T03:00:57.612Z"},"accession":"S-EPMC9780899","cross_references":{"pubmed":["36556152"],"doi":["10.3390/jcm11247537"]}}